Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
10.1038/nbt.1515
Crossref journal-article
Springer Science and Business Media LLC
Nature Biotechnology (297)
Bibliography

Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2008). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nature Biotechnology, 27(1), 59–65.

Authors 6
  1. Kevin D Foust (first)
  2. Emily Nurre (additional)
  3. Chrystal L Montgomery (additional)
  4. Anna Hernandez (additional)
  5. Curtis M Chan (additional)
  6. Brian K Kaspar (additional)
References 37 Referenced 1,208
  1. Pardridge, W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. Drug Discov. 1, 131–139 (2002). (10.1038/nrd725) / Nat. Rev. Drug Discov. by WM Pardridge (2002)
  2. Kaspar, B.K., Llado, J., Sherkat, N., Rothstein, J.D. & Gage, F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839–842 (2003). (10.1126/science.1086137) / Science by BK Kaspar (2003)
  3. Azzouz, M. et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J. Clin. Invest. 114, 1726–1731 (2004). (10.1172/JCI22922) / J. Clin. Invest. by M Azzouz (2004)
  4. Azzouz, M. et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413–417 (2004). (10.1038/nature02544) / Nature by M Azzouz (2004)
  5. Ralph, G.S. et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11, 429–433 (2005). (10.1038/nm1205) / Nat. Med. by GS Ralph (2005)
  6. Kaplitt, M.G. et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369, 2097–2105 (2007). (10.1016/S0140-6736(07)60982-9) / Lancet by MG Kaplitt (2007)
  7. Marks, W.J. Jr. et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 7, 400–408 (2008). (10.1016/S1474-4422(08)70065-6) / Lancet Neurol. by WJ Marks Jr. (2008)
  8. Worgall, S. et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum. Gene Ther. 19, 463–474 (2008). (10.1089/hum.2008.022) / Hum. Gene Ther. by S Worgall (2008)
  9. Blankinship, M.J. et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 10, 671–678 (2004). (10.1016/j.ymthe.2004.07.016) / Mol. Ther. by MJ Blankinship (2004)
  10. Wang, Z. et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321–328 (2005). (10.1038/nbt1073) / Nat. Biotechnol. by Z Wang (2005)
  11. Inagaki, K. et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45–53 (2006). (10.1016/j.ymthe.2006.03.014) / Mol. Ther. by K Inagaki (2006)
  12. Nakai, H. et al. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J. Virol. 79, 214–224 (2005). (10.1128/JVI.79.1.214-224.2005) / J. Virol. by H Nakai (2005)
  13. Pacak, C.A. et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3–e9 (2006). (10.1161/01.RES.0000237661.18885.f6) / Circ. Res. by CA Pacak (2006)
  14. Towne, C., Raoul, C., Schneider, B.L. & Aebischer, P. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol. Ther. 16, 1018–1025 (2008). (10.1038/mt.2008.73) / Mol. Ther. by C Towne (2008)
  15. Foust, K.D., Poirier, A., Pacak, C.A., Mandel, R.J. & Flotte, T.R. Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons. Hum. Gene Ther. 19, 61–70 (2008). (10.1089/hum.2007.093) / Hum. Gene Ther. by KD Foust (2008)
  16. Gao, G. et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381–6388 (2004). (10.1128/JVI.78.12.6381-6388.2004) / J. Virol. by G Gao (2004)
  17. Cearley, C.N. & Wolfe, J.H. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528–537 (2006). (10.1016/j.ymthe.2005.11.015) / Mol. Ther. by CN Cearley (2006)
  18. Akache, B. et al. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80, 9831–9836 (2006). (10.1128/JVI.00878-06) / J. Virol. by B Akache (2006)
  19. McCarty, D.M. et al. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 10, 2112–2118 (2003). (10.1038/sj.gt.3302134) / Gene Ther. by DM McCarty (2003)
  20. Klein, R.L., Dayton, R.D., Tatom, J.B., Henderson, K.M. & Henning, P.P. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol. Ther. 16, 89–96 (2008). (10.1038/sj.mt.6300331) / Mol. Ther. by RL Klein (2008)
  21. Cearley, C.N. et al. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol. Ther. 16, 1710–1718 (2008). (10.1038/mt.2008.166) / Mol. Ther. by CN Cearley (2008)
  22. Kaspar, B.K. et al. Targeted retrograde gene delivery for neuronal protection. Mol. Ther. 5, 50–56 (2002). (10.1006/mthe.2001.0520) / Mol. Ther. by BK Kaspar (2002)
  23. Miller, T.M. et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103, 19546–19551 (2006). (10.1073/pnas.0609411103) / Proc. Natl. Acad. Sci. USA by TM Miller (2006)
  24. Hollis, E.R., II, Kadoya, K., Hirsch, M., Samulski, R.J. & Tuszynski, M.H. Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol. Ther. 16, 296–301 (2008). (10.1038/sj.mt.6300367) / Mol. Ther. by ER, Hollis II (2008)
  25. Abbott, N.J., Ronnback, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41–53 (2006). (10.1038/nrn1824) / Nat. Rev. Neurosci. by NJ Abbott (2006)
  26. Abbott, N.J. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25, 5–23 (2005). (10.1007/s10571-004-1374-y) / Cell. Mol. Neurobiol. by NJ Abbott (2005)
  27. Baughan, T. et al. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Mol. Ther. 14, 54–62 (2006). (10.1016/j.ymthe.2006.01.012) / Mol. Ther. by T Baughan (2006)
  28. Siegel, R.M. & Callaway, E.M. Francis Crick's legacy for neuroscience: between the alpha and the Omega. PLoS Biol. 2, e419 (2004). (10.1371/journal.pbio.0020419) / PLoS Biol. by RM Siegel (2004)
  29. Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251–253 (2008). (10.1038/nn2047) / Nat. Neurosci. by K Yamanaka (2008)
  30. Dodge, J.C. et al. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol. Ther. 16, 1056–1064 (2008). (10.1038/mt.2008.60) / Mol. Ther. by JC Dodge (2008)
  31. Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820–5825 (2005). (10.1073/pnas.0501507102) / Proc. Natl. Acad. Sci. USA by SQ Harper (2005)
  32. Rodriguez-Lebron, E., Denovan-Wright, E.M., Nash, K., Lewin, A.S. & Mandel, R.J. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618–633 (2005). (10.1016/j.ymthe.2005.05.006) / Mol. Ther. by E Rodriguez-Lebron (2005)
  33. Maheshri, N., Koerber, J.T., Kaspar, B.K. & Schaffer, D.V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24, 198–204 (2006). (10.1038/nbt1182) / Nat. Biotechnol. by N Maheshri (2006)
  34. Li, W. et al. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol. Ther. 16, 1252–1260 (2008). (10.1038/mt.2008.100) / Mol. Ther. by W Li (2008)
  35. Koerber, J.T., Jang, J.H. & Schaffer, D.V. DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol. Ther. 16, 1703–1709 (2008). (10.1038/mt.2008.167) / Mol. Ther. by JT Koerber (2008)
  36. Haidet, A.M. et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc. Natl. Acad. Sci. USA 105, 4318–4322 (2008). (10.1073/pnas.0709144105) / Proc. Natl. Acad. Sci. USA by AM Haidet (2008)
  37. Kempermann, G., Kuhn, H.G. & Gage, F.H. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc. Natl. Acad. Sci. USA 94, 10409–10414 (1997). (10.1073/pnas.94.19.10409) / Proc. Natl. Acad. Sci. USA by G Kempermann (1997)
Dates
Type When
Created 16 years, 8 months ago (Dec. 21, 2008, 2:22 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 2:15 p.m.)
Indexed 2 days, 2 hours ago (Aug. 26, 2025, 2:56 a.m.)
Issued 16 years, 8 months ago (Dec. 21, 2008)
Published 16 years, 8 months ago (Dec. 21, 2008)
Published Online 16 years, 8 months ago (Dec. 21, 2008)
Published Print 16 years, 7 months ago (Jan. 1, 2009)
Funders 0

None

@article{Foust_2008, title={Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes}, volume={27}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/nbt.1515}, DOI={10.1038/nbt.1515}, number={1}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Foust, Kevin D and Nurre, Emily and Montgomery, Chrystal L and Hernandez, Anna and Chan, Curtis M and Kaspar, Brian K}, year={2008}, month=dec, pages={59–65} }